Angeliki Mela
5PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 12, 2026
IDH-mutant inhibitors enhance the sensitivity of IDH1-mutant gliomas to cysteine-methionine deprivation and ferroptosis.Angeliki Mela, Abby Brand, Aayushi Mahajan
|Feb 19, 2024
A pharmacological toolkit for human microglia identifies Topoisomerase I inhibitors as immunomodulators for Alzheimer's disease.Verena Haage, John F Tuddenham, Natacha Comandante-Lou
|Feb 09, 2024
EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor.Lisa Sprinzen, Franklin Garcia, Angeliki Mela
|Jan 31, 2024
Glioma-Induced Alterations in Excitatory Neurons are Reversed by mTOR Inhibition.Alexander R Goldberg, Athanassios Dovas, Daniela Torres
|Mar 02, 2023
Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism.Pavan S Upadhyayula, Dominique M Higgins, Angeliki Mela
Pageof 1
Frequent Collaborators
3 joint publications
Jeffrey N Bruce
3 joint publications
Peter Canoll
2 joint publications
Peter A Sims
2 joint publications
Matei A Banu
1 joint publications
Pavan S Upadhyayula
1 joint publications
Trang T T Nguyen
1 joint publications
Benjamin L Shapiro
1 joint publications
Markus D Siegelin
1 joint publications
Brent R Stockwell
1 joint publications
Alexander R Goldberg
